Page last updated: 2024-11-06

benzimidazole and Obesity

benzimidazole has been researched along with Obesity in 4 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
" Compound 18c demonstrates in vivo CB1 antagonist efficacy (CB1 agonist induced hypothermia model) and is orally bioavailable in rat."1.36Identification and hit-to-lead optimization of a novel class of CB1 antagonists. ( Baker, J; Cowley, P; Edwards, D; Ho, KK; Jokiel, P; Letourneau, JJ; McAleer, L; Ohlmeyer, MH; Olson, J; Riviello, CM; Swanson, RN; Ward, N; Webb, ML; Yang, J, 2010)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Letourneau, JJ1
Jokiel, P1
Olson, J1
Riviello, CM1
Ho, KK1
McAleer, L1
Yang, J1
Swanson, RN1
Baker, J1
Cowley, P1
Edwards, D1
Ward, N1
Ohlmeyer, MH1
Webb, ML1
Lee, K1
Goo, JI1
Jung, HY1
Kim, M1
Boovanahalli, SK1
Park, HR1
Kim, MO1
Kim, DH1
Lee, HS1
Choi, Y1
Tamura, Y1
Hayashi, K1
Omori, N1
Nishiura, Y1
Watanabe, K1
Tanaka, N1
Fujioka, M1
Kouyama, N1
Yukimasa, A1
Tanaka, Y1
Chiba, T1
Tanioka, H1
Nambu, H1
Yukioka, H1
Sato, H1
Okuno, T1
Carpenter, AJ1
Al-Barazanji, KA1
Barvian, KK1
Bishop, MJ1
Britt, CS1
Cooper, JP1
Goetz, AS1
Grizzle, MK1
Hertzog, DL1
Ignar, DM1
Morgan, RO1
Peckham, GE1
Speake, JD1
Swain, WR1

Other Studies

4 other studies available for benzimidazole and Obesity

ArticleYear
Identification and hit-to-lead optimization of a novel class of CB1 antagonists.
    Bioorganic & medicinal chemistry letters, 2010, Sep-15, Volume: 20, Issue:18

    Topics: Animals; Benzimidazoles; Humans; Hypothermia; Indoles; Male; Mice; Microsomes, Liver; Obesity; Rats;

2010
Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Benzimidazoles; Diacylglycerol O-Acyltransferase; Dose-Response Relationship, Drug; Drug Di

2012
Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profile.
    Bioorganic & medicinal chemistry letters, 2013, Jan-01, Volume: 23, Issue:1

    Topics: Administration, Oral; Animals; Anti-Obesity Agents; Benzimidazoles; Cytochrome P-450 Enzyme Inhibito

2013
Novel benzimidazole-based MCH R1 antagonists.
    Bioorganic & medicinal chemistry letters, 2006, Oct-01, Volume: 16, Issue:19

    Topics: Animals; Benzimidazoles; Biological Availability; Body Composition; Dose-Response Relationship, Drug

2006